WebDoctor Encyclopedia

Endocrine Lymphomas

Primary thyroid lymphoma

Primary thyroid lymphoma is a lymphoma that starts in the thyroid, usually in older women with Hashimoto's thyroiditis. A quickly growing neck lump is the classic sign, and treatment with chemoimmunotherapy or radiotherapy often cures it.

Medically reviewed Last reviewed October 20, 2026

What is primary thyroid lymphoma?

Primary thyroid lymphoma is a cancer of the immune system that starts in the thyroid gland. The thyroid is a butterfly-shaped gland at the front of the neck that makes hormones controlling the body’s metabolism. Lymphoma is a cancer of lymphocytes, white blood cells that normally help fight infection.

The thyroid does not usually contain much lymphoid tissue. In people with long-standing Hashimoto’s thyroiditis, however, the immune system attacks the thyroid and fills it with lymphocytes. Over many years, one of these lymphocytes can become cancerous. This explains why most people with thyroid lymphoma also have evidence of Hashimoto’s thyroiditis (Travaglino et al., 2020).

Primary thyroid lymphoma is rare. It accounts for only a small proportion of thyroid cancers and of lymphomas that arise outside the lymph nodes (Stein and Wartofsky, 2013). It mostly affects women over 60. The typical sign is a neck lump or goitre that grows quickly over weeks, sometimes causing difficulty swallowing or breathing.

The two main types are diffuse large B-cell lymphoma (DLBCL), which is fast-growing, and MALT lymphoma, which is slow-growing. Unlike most thyroid cancers, thyroid lymphoma is usually treated with chemotherapy, immunotherapy and radiotherapy rather than major surgery. Many people are cured, especially when the disease is confined to the neck.

1. Key facts at a glance

Feature Details
Type of cancer Non-Hodgkin lymphoma arising in the thyroid
How common Rare; a small fraction of thyroid cancers
Who is affected Mostly women, usually over 60
Main risk factor Hashimoto’s thyroiditis
Usual first sign A rapidly enlarging neck lump or goitre
Main types Diffuse large B-cell lymphoma, MALT lymphoma
Diagnosis Ultrasound and biopsy, often core needle biopsy
Main treatment Chemoimmunotherapy (R-CHOP) and/or radiotherapy
Outlook Good for MALT lymphoma; more variable for DLBCL

2. Types

Type Share of cases Behaviour Usual treatment
Diffuse large B-cell lymphoma (DLBCL) The most common type Aggressive, fast-growing R-CHOP chemoimmunotherapy, often with radiotherapy
MALT lymphoma (extranodal marginal zone lymphoma) The second most common Slow-growing Radiotherapy alone or surgery for localised disease
Mixed DLBCL and MALT Some cases Treated as DLBCL As for DLBCL
Follicular lymphoma Uncommon Usually slow-growing Radiotherapy or other options
Other types (Hodgkin, Burkitt, T-cell) Rare Variable Specific regimens

In a 40-year series from a UK lymphoma centre, 50 of 70 patients had DLBCL and 13 had MALT lymphoma (Alzouebi et al., 2012).

MALT and DLBCL compared

Feature MALT lymphoma DLBCL
Growth Slow, over months or years Rapid, over weeks
Hashimoto’s thyroiditis Very common Common, but less so
Pressure symptoms Less frequent More frequent
Spread beyond the neck Uncommon More likely
Treatment Local treatment often sufficient Systemic treatment needed
Outlook Very good Good when localised; poorer when advanced

3. Causes and risk factors

Risk factor Notes
Hashimoto’s thyroiditis Found in about 79% of patients when any evidence is counted (Travaglino et al., 2020)
Female sex Reflects the higher rate of Hashimoto’s in women
Age over 60 Median age about 70 in the Sheffield series
Long-standing immune activity in the thyroid Chronic stimulation of lymphocytes

A pooled analysis of over 1,300 cases found evidence of Hashimoto’s thyroiditis in roughly four out of five patients. It was found more often with MALT lymphoma than with DLBCL. Only about half of these patients had been known to have the condition before their lymphoma was found (Travaglino et al., 2020).

Hashimoto’s is very common, and the great majority of people with it never develop lymphoma. However, people with Hashimoto’s should report a new or rapidly growing neck swelling promptly.

4. How does it look

On ultrasound

Feature Description
Pattern A large, very dark (hypoechoic) area, sometimes involving the whole gland
Posterior enhancement Brighter echoes behind the mass, a feature suggesting lymphoma (Stein and Wartofsky, 2013)
Background gland Changes of thyroiditis
Lymph nodes Enlarged neck nodes in some patients

Other imaging

Test What it shows
CT of the neck and chest Size of the mass and pressure on the windpipe
PET-CT Stage and spread beyond the thyroid

Under the microscope

Type Appearance
DLBCL Sheets of large abnormal B cells that replace the thyroid tissue
MALT lymphoma Small lymphocytes infiltrating thyroid follicles, forming “lymphoepithelial lesions”
Supporting tests Immunostains (CD20 and others), flow cytometry and genetic tests to show the cells are cancerous

5. Symptoms

Common symptoms

  • A rapidly growing lump in the front of the neck
  • Difficulty swallowing
  • A hoarse voice
  • Breathlessness or noisy breathing caused by pressure on the windpipe

Less common symptoms

Symptom Notes
Fever, drenching night sweats, weight loss So-called B symptoms; more common with DLBCL
Tiredness, weight gain, feeling cold Underactive thyroid (hypothyroidism)
Swollen glands elsewhere Spread beyond the thyroid
Swelling of the face and neck veins Pressure on large veins in the chest

When to seek urgent help

Seek urgent medical help for difficulty breathing, noisy breathing (stridor) or inability to swallow. A neck lump that grows over weeks should be assessed quickly, especially in someone with Hashimoto’s thyroiditis.

6. Diagnosis

Test Purpose
Neck examination Size, firmness and fixation of the lump
Thyroid function and antibodies Hypothyroidism and Hashimoto’s thyroiditis
Neck ultrasound Characterises the lump
Fine-needle aspiration with flow cytometry Can diagnose lymphoma in experienced hands
Core needle biopsy Provides more tissue; often preferred
Surgical biopsy When needle tests are inconclusive
PET-CT Staging
Blood tests (LDH, blood count) Assess disease activity and risk
Bone marrow biopsy Selected cases

A fine-needle sample may be enough to make the diagnosis when flow cytometry and experienced pathologists are available. Confirmation by biopsy remains essential (Stein and Wartofsky, 2013).

Distinguishing lymphoma from anaplastic thyroid cancer

Feature Thyroid lymphoma Anaplastic thyroid cancer
Growth Rapid Very rapid
Background Hashimoto’s thyroiditis Often a long-standing goitre
Treatment Chemotherapy and radiotherapy Surgery, radiotherapy, targeted drugs
Outlook Often curable Very poor

Because the treatments and outlook differ so much, an accurate biopsy is vital.

Staging

Stage Meaning
Stage IE Lymphoma limited to the thyroid
Stage IIE Thyroid plus lymph nodes on the same side of the diaphragm
Stage IIIE-IV Spread on both sides of the diaphragm or to other organs

About half of people with thyroid lymphoma have stage IE disease (Tang et al., 2024).

7. Treatment

Treatment depends on the type and stage of the lymphoma.

Situation Typical treatment
Localised MALT lymphoma Radiotherapy to the neck, or surgery if already fully removed
Advanced MALT lymphoma Rituximab-based treatment or watchful waiting
Localised DLBCL Short-course R-CHOP followed by radiotherapy, or R-CHOP alone
Advanced DLBCL Six cycles of R-CHOP, with radiotherapy in some cases
Airway compression Steroids and urgent treatment; rarely an airway procedure

Radiotherapy can control localised MALT lymphoma, while aggressive types or widespread disease need chemotherapy combined with radiotherapy (Stein and Wartofsky, 2013). In the Sheffield series, radiotherapy alone was enough for stage I-II low-grade disease if treatment was needed after surgery (Alzouebi et al., 2012).

Role of surgery

Situation Notes
Diagnosis Surgical biopsy if needle biopsy is inconclusive
Stage IE disease A large SEER analysis found surgery alone gave similar disease-specific survival to other treatments in selected patients (Tang et al., 2024)
Advanced or aggressive disease Surgery is not the main treatment

In the study by Tang and colleagues, surgery alone also meant fewer complications, shorter treatment and lower costs in a smaller hospital cohort. This option is generally considered for small, localised tumours that can be removed easily, especially MALT lymphoma.

R-CHOP explained

Drug Type
R – Rituximab Antibody targeting CD20 on B cells
C – Cyclophosphamide Chemotherapy
H – Doxorubicin (hydroxydaunorubicin) Chemotherapy
O – Vincristine (Oncovin) Chemotherapy
P – Prednisolone Steroid

What a course of treatment looks like

Phase What happens Typical length
Diagnosis and staging Ultrasound, biopsy, PET-CT, blood tests 1-3 weeks
Chemoimmunotherapy R-CHOP every 2-3 weeks, given as a day-case infusion About 2-5 months
Interim scan PET-CT to check response Midway or at the end
Radiotherapy Weekday sessions to the neck About 2-4 weeks
End-of-treatment scan Confirms remission 6-8 weeks after treatment

When the airway is at risk

A fast-growing thyroid lymphoma can narrow the windpipe. In this situation, doctors act quickly. High-dose steroids often shrink the lymphoma within days, and chemotherapy is started urgently once the biopsy is taken.

Very rarely, a tracheostomy or airway stent is needed. Ask your team what warning signs to watch for while waiting for results.

Side effects

Treatment Possible side effects
R-CHOP Infection risk, hair loss, tiredness, nerve tingling, nausea, heart effects with doxorubicin
Neck radiotherapy Sore throat, difficulty swallowing, skin redness, dry mouth
Long term after radiotherapy Underactive thyroid, neck stiffness
Thyroid surgery Hoarse voice, low calcium, need for thyroid hormone

8. Outlook (prognosis)

Factor Effect
MALT lymphoma Very good outlook
DLBCL Good when localised; poorer when advanced
Stage IE or IIE Better outlook
B symptoms, high LDH, older age, poor fitness Poorer outlook
Pressure on the airway at diagnosis Linked with more aggressive disease

Survival in the Sheffield series

Type Five-year survival
DLBCL 45%
MALT lymphoma 62%
Indolent B-cell lymphoma (other) 75%

These figures come from patients treated over four decades, many before rituximab was available, and from an older group with a median age of about 70 (Alzouebi et al., 2012). Results with modern treatment are generally better.

9. Follow-up

Follow-up Purpose
Clinic visits every 3-6 months for 2 years Check for relapse and side effects
Then every 6-12 months Longer-term monitoring
Thyroid function tests Many patients need thyroid hormone replacement
Imaging Only if symptoms or signs suggest relapse
Heart checks After doxorubicin, if symptoms develop

10. Living with thyroid lymphoma

  • Take thyroid hormone tablets as prescribed, and have regular blood tests
  • Report fever promptly during chemotherapy
  • Use soft foods and painkillers if radiotherapy makes swallowing sore
  • Look after your mouth and teeth after neck radiotherapy
  • Stay active to help with fatigue
  • Have the flu and other recommended vaccines, as advised by your team
  • Report a new neck lump, swallowing difficulty or night sweats
  • Seek support from lymphoma charities and patient groups

11. Frequently asked questions

Question Answer
Is thyroid lymphoma the same as thyroid cancer? It is a cancer in the thyroid, but it is a lymphoma, so it is treated differently
Did my Hashimoto’s cause it? It raises the risk, but very few people with Hashimoto’s develop lymphoma
Will my thyroid be removed? Usually not; surgery is mainly used for diagnosis or small localised disease
Can it be cured? Yes, many people are cured, especially with localised disease
Will I need thyroid tablets? Often, either because of Hashimoto’s or after radiotherapy
Can it come back? Yes, so regular follow-up is important; relapses can usually be treated
Can I keep working? Many people work part-time during treatment, depending on how they feel
Is it inherited? No
Should my family be checked for Hashimoto’s? Not routinely; anyone with thyroid symptoms should see their doctor
Will I lose my hair? Usually with R-CHOP, but it grows back after treatment

12. Questions to ask your care team

  • What type of thyroid lymphoma do I have?
  • What stage is it?
  • Do I need chemotherapy, radiotherapy or both?
  • Is surgery an option in my case?
  • How will treatment affect my thyroid function?
  • What side effects should I watch for?
  • What follow-up will I need?
  • Who do I contact if I have breathing or swallowing problems?
  • Will I need thyroid hormone tablets long term?

Resources

  1. Alzouebi, M. et al. (2012) ‘Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre’, International Journal of Oncology, 40(6), pp. 2075-2080.
  2. Stein, S.A. and Wartofsky, L. (2013) ‘Primary thyroid lymphoma: a clinical review’, Journal of Clinical Endocrinology and Metabolism, 98(8), pp. 3131-3138.
  3. Tang, Y. et al. (2024) ‘Surgery is a viable treatment option for stage IE primary thyroid lymphoma’, Annals of Surgical Oncology, 31(2), pp. 1108-1115.
  4. Travaglino, A. et al. (2020) ‘Hashimoto thyroiditis in primary thyroid non-Hodgkin lymphoma’, American Journal of Clinical Pathology, 153(2), pp. 156-164.
  5. National Cancer Institute (2026) Non-Hodgkin Lymphoma Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq (Accessed: October 2026).

Prepared by the editorial team, October 2026.